Automation-enabled assay development for high throughput screening
SPT Labtech Japan株式会社
About this webinar Respective assays range from simple binding analysis to complex phenotypic assays with multiple read-out parameters. In order to understand the molecular mode of action (mMoA) of compounds as early as possible in the drug identification process, Merck also implement mMoA assays, such as competition assays or jump dilution assays into the HTS campaigns.
- 開催日時 常時開設中
- 参加費 無料